Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sucrose. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 1/20 | 0.73 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.73 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | LDHA | P00338 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sucrose SCHEMBL10405566 | 1.00 | CDK1 (0.73) | CDK1CCNB1CA2CA9LDHA | |
| Sucrose SCHEMBL1272574 | 0.99 | CDK1 (0.71) | CDK1CCNB1CA2CA9LDHA | |
| Sucrose SCHEMBL15656196 | 0.99 | CDK1 (0.71) | CDK1CCNB1CA2CA9LDHA | |
| Sucrose SCHEMBL3797240 | 0.99 | CDK1 (0.71) | CDK1CCNB1CA2CA9LDHA | |
| Sucrose SCHEMBL9704445 | 0.99 | CDK1 (0.71) | CDK1CCNB1CA2CA9LDHA | |
| Sucrose SCHEMBL5972243 | 0.99 | CDK1 (0.71) | CDK1CCNB1CA2CA9LDHA | |
| Sucrose SCHEMBL6376479 | 0.99 | CDK1 (0.71) | CDK1CCNB1CA2CA9LDHA | |
| Sucrose SCHEMBL2065050 | 0.99 | CDK1 (0.71) | CDK1CCNB1CA2CA9LDHA | |
| Sucrose SCHEMBL9747719 | 0.99 | CDK1 (0.71) | CDK1CCNB1CA2CA9LDHA | |
| Sucrose SCHEMBL1001769 | 0.99 | CDK1 (0.71) | CDK1CCNB1CA2CA9LDHA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 546 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240226138-A9 | WATER-ACTIVATED MUCOADHESIVE COMPOSITIONS TO REDUCE INTESTINAL ABSORPTION OF NUTRIENTS | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2024-07-11 | — | — | US | claimed |
| US-20240131053-A1 | WATER-ACTIVATED MUCOADHESIVE COMPOSITIONS TO REDUCE INTESTINAL ABSORPTION OF NUTRIENTS | BRIGHAM & WOMENS HOSPITAL INC (US) | 2024-04-25 | — | — | US | claimed |
| US-11894524-B2 | Positive electrode plate, and electrochemical apparatus and device associated therewith | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2024-02-06 | — | — | US | claimed |
| EP-3352738-B1 | WATER-ACTIVATED MUCOADHESIVE COMPOSITIONS TO REDUCE INTESTINAL ABSORPTION OF NUTRIENTS | BRIGHAM & WOMENS HOSPITAL INC (US) | 2024-01-17 | — | — | EP | claimed |
| US-20230310314-A1 | MUCOADHESIVE COMPOSITIONS FOR DIRECTIONAL DELIVERY OF ACTIVE AGENTS | ALTRIXBIO, INC. (US) | 2023-10-05 | — | — | US | claimed |
| WO-2023169433-A1 | POLYMER-COATED NANOPARTICLES AND PREPARATION METHOD THEREFOR | 晟迪生物医药(苏州)有限公司 | 2023-09-14 | — | — | WO | claimed |
| EP-3979397-B1 | POSITIVE ELECTRODE PLATE AND ELECTROCHEMICAL DEVICE AND EQUIPMENT ASSOCIATED THEREWITH | CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) | 2023-09-06 | — | — | EP | claimed |
| WO-2023164706-A1 | MUCOADHESIVE COMPOSITIONS FOR DIRECTIONAL DELIVERY OF ACTIVE AGENTS | ALTRIXBIO, INC. (US) | 2023-08-31 | — | — | WO | claimed |
| CN-114916494-B | Method for establishing bee enteritis model and application thereof | 中国农业大学 | 2023-06-20 | — | — | CN | claimed |
| US-20230141842-A1 | Compounds to Modulate Intestinal Absorption of Nutrients | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2023-05-11 | — | — | US | claimed |
| EP-0731713-A1 | METAL-ION CHELATES WITH ACIDIC SACCHARIDES AND GLYCOSAMINOGLYCANS | Access Pharmaceuticals Inc. (US) | 1996-09-18 | — | — | EP | claimed |
| EP-0726781-A1 | IN VIVO AGENTS COMPRISING RADIOACTIVE METAL-ION CHELATES WITH ACIDIC SACCHARIDES AND GLYCOSAMINOGLYCANS, GIVING IMPROVED SITE-SELECTIVE LOCALIZATION, UPTAKE MECHANISM, SENSITIVITY AND KINETIC-SPATIAL PROFILES | Access Pharmaceuticals Inc. (US) | 1996-08-21 | — | — | EP | claimed |
| EP-0469010-B1 | COSMETIC COMPOSITION | BM RES AS (DK) | 1996-02-28 | — | — | EP | claimed |
| WO-1995014491-A9 | METAL-ION CHELATES WITH ACIDIC SACCHARIDES AND GLYCOSAMINOGLYCANS | — | 1995-09-28 | — | — | WO | claimed |
| WO-1995017898-A1 | A METHOD OF PREVENTING OR REDUCING THE RISK OF INFECTION BY BACTERIAL PATHOGENS UTILIZING SIMPLE AND CONJUGATED DEXTRANS | NOVADEX PHARMACEUTICALS LIMITED (CA) | 1995-07-06 | — | — | WO | claimed |
| WO-1995014492-A2 | IN VIVO AGENTS COMPRISING RADIOACTIVE METAL-ION CHELATES WITH ACIDIC SACCHARIDES AND GLYCOSAMINOGLYCANS, GIVING IMPROVED SITE-SELECTIVE LOCALIZATION, UPTAKE MECHANISM, SENSITIVITY AND KINETIC-SPATIAL PROFILES | ACCESS PHARMACEUTICALS, INC. (US) | 1995-06-01 | — | — | WO | claimed |
| WO-1995014491-A2 | METAL-ION CHELATES WITH ACIDIC SACCHARIDES AND GLYCOSAMINOGLYCANS | ACCESS PHARMACEUTICALS, INC. (US) | 1995-06-01 | — | — | WO | claimed |
| WO-1994000476-A1 | USE OF WATER-SOLUBLE SUCROSES FOR THE TREATMENT AND/OR PREVENTION OF LESION OR INFLAMMATION IN THE DIGESTIVE TRACT | BUKH MEDITEC A/S (DK) | 1994-01-06 | — | — | WO | claimed |
| EP-0404792-B1 | USE OF SULPHATED SUCROSE IN PREPARATIONS FOR THE TREATMENT OF TEETH AND THEIR SUPPORTING TISSUE | BUKH MEDITEC (DK) | 1993-10-20 | — | — | EP | claimed |
| US-5023072-A | Paramagnetic/superparamagnetic/ferromagnetic sucrose sulfate compositions for magnetic resonance imaging of the gastrointestinal tract | UNIVERSITY OF NEW MEXICO (US) | 1991-06-11 | — | — | US | claimed |